Webinar: Post-ASCO Melanoma Research Update
Each year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings together leading cancer researchers and physicians from around…
05/21/2026
Webinar: Post-ASCO Melanoma Research Update
Each year, the American Society of Clinical Oncology (ASCO) Annual Meeting brings together leading cancer researchers and physicians from around…
|
05/04/2026
Melanoma Monday: Every Day. Everywhere.
May is Melanoma Awareness Month—but melanoma doesn’t follow a calendar. It doesn’t wait for summer vacations or long afternoons at…
04/27/2026
Lilly Pulitzer and AIM at Melanoma Partner for 5th Annual Community Giving Event
AIM at Melanoma is proud to partner once again with Lilly Pulitzer for their annual Community Giving Event. Now in…
|
04/19/2026
KIMMTRAK doubles the likelihood of being alive at five years for firstline HLA-A*02:01+ patients with metastatic uveal melanoma
OS benefit observed across key subgroups, including patients with high tumor burden, elevated LDH, and extrahepatic disease as well as…
|
|
04/10/2026
FDA Does Not Approve RP1 in Combination with Nivolumab for Advanced Melanoma: What This Means for Patients
On April 10, 2026, the U.S. Food and Drug Administration (FDA) issued a decision not to approve the resubmission of…
|
|
04/07/2026
2026 National Sunscreen Partner
We are proud to share that burnd Sunscreen has joined AIM at Melanoma as our 2026 National Sunscreen Partner. This…
|
04/07/2026
Young Adult Cancer & Mental Health
In this episode of Beyond the Clinic: Living Well with Melanoma, host Dr. Samantha Siegel sits down with Dr. Victoria…
|
04/02/2026
Uveal Melanoma Webinar: Part II — Navigating Treatment in the Metastatic Setting
Presented in partnership with Save Your Skin Foundation and Ocumel CanadaOcumel Canada (OC), is powered by Save Your Skin Foundation,…
03/26/2026
Wade Watson, Stage III Melanoma Survivor
A Diagnosis That Changed Everything In early 2021, Wade Watson and his father received life-changing news just weeks apart. His…
|
03/26/2026
Advocates Renew Call for RP1 Approval
As the U.S. Food and Drug Administration approaches a pivotal decision on a potential new treatment for advanced melanoma, patient…
|
Recent Posts
May. 21, 2026
Webinar: Post-ASCO Melanoma Research Update
May. 04, 2026
Melanoma Monday: Every Day. Everywhere.
Apr. 27, 2026
Lilly Pulitzer and AIM at Melanoma Partner for 5th Annual Community Giving Event
Apr. 19, 2026
KIMMTRAK doubles the likelihood of being alive at five years for firstline HLA-A*02:01+ patients with metastatic uveal melanoma
Apr. 10, 2026